Literature DB >> 22490593

Prevalence and characterization of plasmid-mediated blaESBL with their genetic environment in Escherichia coli and Klebsiella pneumoniae in patients with pneumonia.

Xiao-rong Wang1, Ji-chao Chen, Yu Kang, Ning Jiang, Shu-chang An, Zhan-cheng Gao.   

Abstract

BACKGROUND: The extended spectrum β-lactamase (ESBL)-producing Escherichia coli (E. coli) and Klebsiella pneumoniae (K. pneumoniae) are the major pathogens causing pneumonia and have a significant impact on the clinical course. Limited data exist on molecular characterization of ESBL-producing E. coli and K. pneumoniae that cause pneumonia. The aim of this study was to investigate the comprehensive multilevel characteristics of E. coli and K. pneumoniae causing pneumonia in China for the first time.
METHODS: E. coli (17) and K. pneumoniae (21) isolates responsible for pneumonia were isolated from 1270 specimens collected in a prospective multi-center study in eight teaching hospitals in China from June to December in 2007. The susceptibilities, ESBL confirmation, sequence typing, blaCTX-M and blaSHV genes, their genetic environment and plasmid Inc/rep types were determined.
RESULTS: Sixteen E. coli (94.1%) and eleven K. pneumoniae (52.4%) isolates were ESBL producers. About 77.8% and 66.7% of them were resistance to ciprofloxacin and levofloxacin, and 100% were susceptible to imipenem. The most prevalent ESBL gene was CTX-M-14, followed by SHV-2, CTX-M-15, CTX-M-3, CTX-M-65, SHV-12, SHV-26 and SHV-28. SHV-1 and SHV-11 were also detected and coexisted with blaCTX-Ms in five strains, and three strains contained only SHV-1. All CTX-M-14 were detected ISEcp1 upstream and nine were found IS903 downstream and the majority of them (64.3%) were carried by IncF plasmids. All blaSHV were flanked by recF and deoR, located on IncF, IncN, IncX and IncH plasmids. Two SHV-2, one SHV-1 and the only SHV-28 were further preceded by IS26. Genes lacY and lacZ were detected at further upstream of two blaSHV-1. The K. pneumoniae carrying SHV-28 was susceptible to β-lactams, and no mutations or deletions in gene or promoter sequences were identified to account for susceptibility. Multilocus sequence typing experiments showed the ESBL-producing strains were genetically diverse.
CONCLUSIONS: The rate of occurrence of blaESBL in E. coli and K. pneumoniae causing pneumonia was high, and blaCTX-M-14 was dominant and probably mobilized by ISEcp1 mainly on IncF plasmids. Importantly, unexpressed blaESBL genes may occur in susceptible isolates and hence may have clinical implications.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22490593

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


  15 in total

1.  Development of a multiplex PCR system and its application in detection of blaSHV, blaTEM, blaCTX-M-1, blaCTX-M-9 and blaOXA-1 group genes in clinical Klebsiella pneumoniae and Escherichia coli strains.

Authors:  James O Ogutu; Qingmeng Zhang; Ying Huang; Huo Yan; Lijie Su; Bo Gao; Wenli Zhang; Jizi Zhao; Wenhui Cai; Wenjing Li; Hong Zhao; Yang Chen; Wuqi Song; Xiaobei Chen; Yingmei Fu; Fengmin Zhang
Journal:  J Antibiot (Tokyo)       Date:  2015-06-24       Impact factor: 2.649

2.  Longitudinal surveillance for meningitis by Acinetobacter in a large urban setting in Brazil.

Authors:  T Coelho-Souza; J N Reis; N Martins; I S Martins; A O Menezes; M G Reis; N O Silva; R C S Dias; L W Riley; B M Moreira
Journal:  Clin Microbiol Infect       Date:  2013-02-11       Impact factor: 8.067

3.  Population Structure and Antimicrobial Resistance of Canine Uropathogenic Escherichia coli.

Authors:  Tessa E LeCuyer; Barbara A Byrne; Joshua B Daniels; Dubraska V Diaz-Campos; G Kenitra Hammac; Claire B Miller; Thomas E Besser; Margaret A Davis
Journal:  J Clin Microbiol       Date:  2018-08-27       Impact factor: 5.948

4.  Widespread distribution of CTX-M and plasmid-mediated AmpC β-lactamases in Escherichia coli from Brazilian chicken meat.

Authors:  Larissa Alvarenga Batista Botelho; Gabriela Bergiante Kraychete; Jacqueline Lapa Costa e Silva; Douglas Viller Vieira Regis; Renata Cristina Picão; Beatriz Meurer Moreira; Raquel Regina Bonelli
Journal:  Mem Inst Oswaldo Cruz       Date:  2015-04       Impact factor: 2.743

5.  Phenotypic and Molecular Characterization of Extended-Spectrum β-Lactamase Produced by Escherichia coli, and Klebsiella pneumoniae Isolates in an Educational Hospital.

Authors:  Abolfazl Gholipour; Neda Soleimani; Dariush Shokri; Sina Mobasherizadeh; Mohammad Kardi; Azar Baradaran
Journal:  Jundishapur J Microbiol       Date:  2014-10-01       Impact factor: 0.747

6.  Analysis of drug resistance determinants in Klebsiella pneumoniae isolates from a tertiary-care hospital in Beijing, China.

Authors:  Bin Li; Yong Yi; Qi Wang; Patrick C Y Woo; Lin Tan; Hua Jing; George F Gao; Cui Hua Liu
Journal:  PLoS One       Date:  2012-07-31       Impact factor: 3.240

7.  Molecular characterization of multidrug-resistant Klebsiella pneumoniae isolates.

Authors:  Xiang-hua Hou; Xiu-yu Song; Xiao-bo Ma; Shi-yang Zhang; Jia-qin Zhang
Journal:  Braz J Microbiol       Date:  2015-07-01       Impact factor: 2.476

8.  Heteroresistance at the single-cell level: adapting to antibiotic stress through a population-based strategy and growth-controlled interphenotypic coordination.

Authors:  Xiaorong Wang; Yu Kang; Chunxiong Luo; Tong Zhao; Lin Liu; Xiangdan Jiang; Rongrong Fu; Shuchang An; Jichao Chen; Ning Jiang; Lufeng Ren; Qi Wang; J Kenneth Baillie; Zhancheng Gao; Jun Yu
Journal:  MBio       Date:  2014-02-11       Impact factor: 7.867

9.  Molecular characterization of clinical multidrug-resistant Klebsiella pneumoniae isolates.

Authors:  Xiaoli Cao; Xuejing Xu; Zhifeng Zhang; Han Shen; Junhao Chen; Kui Zhang
Journal:  Ann Clin Microbiol Antimicrob       Date:  2014-05-01       Impact factor: 3.944

Review 10.  A Review of SHV Extended-Spectrum β-Lactamases: Neglected Yet Ubiquitous.

Authors:  Apostolos Liakopoulos; Dik Mevius; Daniela Ceccarelli
Journal:  Front Microbiol       Date:  2016-09-05       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.